feed,title,long_url,short_url
SeekingAlpha,"Aptevo +7%, expands bispecific platform technology and introduces new bispecific prostate cancer candidate",https://seekingalpha.com/news/3640879,
SeekingAlpha,Celestica reaffirms Q4 2020 guidance and provides an update on JDM business,https://seekingalpha.com/news/3640878,
